Uncategorized

From Big Pharma to specialty: why moving closer to the patient changes everything

Published

on

Working at a Big Pharma has its benefits, but there are limitations too. SERB Pharmaceuticals’ Thomas Kolaras discusses how moving to a midsize company creates new opportunities for sharpened thinking and leadership.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version